{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:25:38Z","timestamp":1785493538665,"version":"3.56.0"},"reference-count":80,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,8,2]]},"abstract":"<jats:p>Recent evidence suggests that about 30%of patients with mild to moderate Alzheimer\u2019s disease (AD) without a known diagnosis of epilepsy may display epileptiform spikes during electroencephalographic (EEG) recordings. These abnormal discharges occur predominantly during sleep and may be associated with accelerated disease progression. Subclinical spikes may represent a relevant target for clinical drug interventions, and there is a clear unmet need for preclinical testing of novel disease modifying agents in suitable animal models. Transgenic rodent models of AD pathology exhibit various forms of epileptiform EEG activity related to the abnormal levels of amyloid species in the brain. Among them, large-amplitude cortical and hippocampal EEG spikes in mouse and rat AD models may be reminiscent of the subclinical epileptiform EEG spikes recorded in some AD patients. This article reports the recommendations of a multidisciplinary panel of experts on optimal EEG markers and experimental designs to measure and report epileptiform activities and their response to symptomatic and disease-modifying drugs in transgenic AD model rodents. These recommendations may harmonize future preclinical EEG studies in the drug discovery research and may increase the comparability of experimental outcomes and their translational clinical value.<\/jats:p>","DOI":"10.3233\/jad-210209","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T16:04:34Z","timestamp":1622563474000},"page":"849-865","source":"Crossref","is-referenced-by-count":8,"title":["Recommendations for Preclinical Testing of Treatments Against Alzheimer\u2019s Disease-Related Epileptiform Spikes in Transgenic Rodent Models"],"prefix":"10.1177","volume":"88","author":[{"given":"Nanxiang","family":"Jin","sequence":"first","affiliation":[{"name":"A. I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Babiloni","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology \u201cVittorio Erspamer\u201d, Sapienza University of Rome, Rome, Italy"},{"name":"Hospital San Raffaele Cassino, Cassino (FR), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmus H.","family":"Drinkenburg","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium"},{"name":"Groningen Institute for Evolutionary Life Sciences, University of Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Haj\u00f3s","sequence":"additional","affiliation":[{"name":"Cognito Therapeutics, Cambridge, MA, USA"},{"name":"Yale School of Medicine, Yale University, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haakon B.","family":"Nygaard","sequence":"additional","affiliation":[{"name":"Division of Neurology and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Tanila","sequence":"additional","affiliation":[{"name":"A. I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-210209_ref1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2011.00251.x","article-title":"Seizures and epilepsy in Alzheimer\u2019s disease","volume":"18","author":"Friedman","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"10.3233\/JAD-210209_ref2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/WAD.0000000000000134","article-title":"Epileptic seizures in Alzheimer disease","volume":"30","author":"Horv\u00e1th","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-210209_ref3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archneurol.2009.130","article-title":"Seizures in Alzheimer disease: Who, when, and how common?","volume":"66","author":"Scarmeas","year":"2009","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-210209_ref4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: Causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-210209_ref5","doi-asserted-by":"crossref","first-page":"e2259","DOI":"10.1212\/WNL.0000000000010612","article-title":"Association of epileptiform abnormalities and seizures in Alzheimer disease","volume":"95","author":"Lam","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-210209_ref6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210209_ref7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm.4330","article-title":"Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer\u2019s disease","volume":"23","author":"Lam","year":"2017","journal-title":"Nat Med"},{"key":"10.3233\/JAD-210209_ref8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3233\/JAD-160994","article-title":"Sleep EEG detects epileptiform activity in Alzheimer\u2019s disease with high sensitivity","volume":"56","author":"Horv\u00e1th","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210209_ref9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000278620","article-title":"Prevalence and clinical significance of epileptiform EEG discharges in a large memory clinic cohort","volume":"29","author":"Liedorp","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-210209_ref10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.clinph.2020.02.015","article-title":"Subclinical epileptiform activity during sleep in Alzheimer\u2019s disease and mild cognitive impairment","volume":"131","author":"Brunetti","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.3233\/JAD-210209_ref11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40266-020-00826-2","article-title":"Treatment of seizures in older patients with dementia","volume":"38","author":"Cretin","year":"2021","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-210209_ref12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-1331.2007.01907.x","article-title":"Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: A prospective observational study","volume":"14","author":"Belcastro","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-210209_ref13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","article-title":"Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease","volume":"17","author":"Cumbo","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.3233\/JAD-210209_ref14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1533317508325095","article-title":"Levetiracetam: A practical option for seizure management in elderly patients with cognitive impairment","volume":"25","author":"Lippa","year":"2010","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-210209_ref15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"key":"10.3233\/JAD-210209_ref16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.nicl.2015.02.009","article-title":"Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance","volume":"7","author":"Bakker","year":"2015","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-210209_ref17","first-page":"489","article-title":"Levetiracetam: A review of its use in epilepsy","volume":"71","author":"Lyseng-Williamson","year":"2011","journal-title":"Drugs"},{"key":"10.3233\/JAD-210209_ref18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-160742","article-title":"Levetiracetam alters oscillatory connectivity in Alzheimer\u2019s disease","volume":"58","author":"Musaeus","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210209_ref19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.3233\/JAD-210209_ref20","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","article-title":"Amyloid \u03b2-induced neuronal hyperexcitability triggers progressive epilepsy","volume":"29","author":"Minkeviciene","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-210209_ref21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3389\/fneur.2019.01151","article-title":"Characterization of epileptic spiking associated with brain amyloidosis in APP\/PS1 mice","volume":"10","author":"Gureviciene","year":"2019","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-210209_ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00393-5","article-title":"Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer\u2019s disease mutations but not by inhibition of BACE1","volume":"15","author":"Johnson","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-210209_ref23","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1038\/srep20119","article-title":"Interictal spikes during sleep are an early defect in the Tg2576 mouse model of \u03b2-amyloid neuropathology","volume":"6","author":"Kam","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-210209_ref24","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-210209_ref25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eplepsyres.2011.01.003","article-title":"Spontaneous epileptiform discharges in a mouse model of Alzheimer\u2019s disease are suppressed by antiepileptic drugs that block sodium channels","volume":"94","author":"Ziyatdinova","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.3233\/JAD-210209_ref26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eplepsyres.2015.02.005","article-title":"Reduction of epileptiform activity by valproic acid in a mouse model of Alzheimer\u2019s disease is not long-lasting after treatment discontinuation","volume":"112","author":"Ziyatdinova","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.3233\/JAD-210209_ref27","doi-asserted-by":"crossref","first-page":"eaaw8954","DOI":"10.1126\/scitranslmed.aaw8954","article-title":"Paroxysmal slow cortical activity in Alzheimer\u2019s disease and epilepsy is associated with blood-brain barrier dysfunction","volume":"11","author":"Milikovsky","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-210209_ref28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neubiorev.2016.09.017","article-title":"Upholding WAG\/Rij rats as a model of absence epileptogenesis: Hidden mechanisms and a new theory on seizure development","volume":"71","author":"Russo","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-210209_ref29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0306-4522(88)90095-4","article-title":"Electric activity in the neocortex of freely moving young and aged rats","volume":"26","author":"Buzs\u00e1ki","year":"1988","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-210209_ref30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneumeth.2015.05.022","article-title":"The genetic absence epilepsy rat from Strasbourg as a model to decipher the neuronal and network mechanisms of generalized idiopathic epilepsies","volume":"260","author":"Depaulis","year":"2016","journal-title":"J Neurosci Methods"},{"key":"10.3233\/JAD-210209_ref31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-018-0433-4","article-title":"Neurophysiological signals as predictive translational biomarkers for Alzheimer\u2019s disease treatment: Effects of donepezil on neuronal network oscillations in TgF344-AD rats","volume":"10","author":"Stoiljkovic","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-210209_ref32","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/cercor\/bhy140","article-title":"Altered cortical and hippocampal excitability in TgF344-AD rats modeling Alzheimer\u2019s disease pathology","volume":"29","author":"Stoiljkovic","year":"2019","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-210209_ref33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archneur.62.3.371","article-title":"Evolving concepts on the pathophysiology of absence seizures: The cortical focus theory","volume":"62","author":"Meeren","year":"2005","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-210209_ref34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0920-1211(91)90055-K","article-title":"Spike-wave discharges and sleep-wake states in rats with absence epilepsy","volume":"9","author":"Drinkenburg","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.3233\/JAD-210209_ref35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2019.03.062","article-title":"Spike\u2013wave discharges and sleep\u2013wake states during circadian desynchronization: No effects of agomelatine upon re-entrainment","volume":"408","author":"Smyk","year":"2019","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-210209_ref36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neurobiolaging.2018.07.009","article-title":"Increased cortical beta power and spike-wave discharges in middle-aged APP\/PS1 mice","volume":"71","author":"Jin","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210209_ref37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ana.410210308","article-title":"Absence seizures in children: Clinical and electroencephalographic features","volume":"21","author":"Holmes","year":"1987","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210209_ref38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0013-4694(96)96612-2","article-title":"On the existence of different types of central beta rhythms below 30Hz","volume":"102","author":"Pfurtscheller","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.3233\/JAD-210209_ref39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/nimg.2000.0660","article-title":"Abnormal reactivity of the \u223c20Hz motor cortex rhythm in Unverricht Lundborg type progressive myoclonus epilepsy","volume":"12","author":"Sil\u00e9n","year":"2000","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-210209_ref40","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1523\/JNEUROSCI.17-17-06783.1997","article-title":"Cellular-synaptic generation of sleep spindles, spike-and-wave discharges, and evoked thalamocortical responses in the neocortex of the rat","volume":"17","author":"Kandel","year":"1997","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-210209_ref41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0031-9384(93)90092-T","article-title":"Aberrant transients in the EEG of epileptic rats: A spectral analytical approach","volume":"54","author":"Drinkenburg","year":"1993","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-210209_ref42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2017.09.026","article-title":"Seizure susceptibility in the APP\/PS1 mouse model of Alzheimer\u2019s disease and relationship with amyloid \u03b2 plaques","volume":"1677","author":"Reyes-Marin","year":"2017","journal-title":"Brain Res"},{"key":"10.3233\/JAD-210209_ref43","doi-asserted-by":"crossref","first-page":"e0119910","DOI":"10.1371\/journal.pone.0119910","article-title":"Early onset of hypersynchronous network activity and expression of a marker of chronic seizures in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"10","author":"Bezzina","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-210209_ref44","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1523\/JNEUROSCI.5171-13.2014","article-title":"Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzheimer\u2019s disease","volume":"34","author":"Born","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-210209_ref45","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.1446-19.2019","article-title":"SIRT3 haploinsufficiency aggravates loss of GABAergic interneurons and neuronal network hyperexcitability in an Alzheimer\u2019s disease model","volume":"40","author":"Cheng","year":"2020","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-210209_ref46","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-210209_ref47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-015-0110-9","article-title":"Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer\u2019s disease mouse model","volume":"7","author":"Nygaard","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-210209_ref48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02244214","article-title":"Tetrahydroaminoacridine inhibits high voltage spindle activity in aged rats after acute and chronic treatment","volume":"103","author":"Riekkinen","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-210209_ref49","doi-asserted-by":"crossref","unstructured":"Brown R , Lam AD , Gonzalez-Sulser A , Ying A , Jones M , Chou RCC , Tzioras M , Jordan CY , Jedrasiak-Cape I , Hemonnot AL , Jaoude MA , Cole AJ , Cash SS , Saito T , Saido T , Ribchester RR , Hashemi K , Oren I (2018) Circadian and brain state modulation of network hyperexcitability in Alzheimer\u2019s disease. eNeuro 5, ENEURO.0426-17.2018.","DOI":"10.1523\/ENEURO.0426-17.2018"},{"key":"10.3233\/JAD-210209_ref50","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-180260","article-title":"Sleep and EEG power spectral analysis in three transgenic mouse models of Alzheimer\u2019s disease: APP\/PS1, 3xTgAD, and Tg2576","volume":"64","author":"Kent","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210209_ref51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2019.01.010","article-title":"Delayed daily activity and reduced NREM slow-wave power in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease","volume":"78","author":"Kent","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210209_ref52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0166-4328(02)00058-X","article-title":"Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP+PS1 mice","volume":"134","author":"Liu","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-210209_ref53","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","article-title":"Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease","volume":"24","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-210209_ref54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.3233\/JAD-210209_ref55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-210209_ref56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2009.02.021","article-title":"Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model","volume":"32","author":"R\u00f6nnb\u00e4ck","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210209_ref57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(02)00586-X","article-title":"Theta oscillations in the hippocampus","volume":"33","author":"Buzs\u00e1ki","year":"2002","journal-title":"Neuron"},{"key":"10.3233\/JAD-210209_ref58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S1355617715000995","article-title":"Measuring cortical connectivity in Alzheimer\u2019s disease as a brain neural network pathology: Toward clinical applications","volume":"22","author":"Teipel","year":"2016","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-210209_ref59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0079-6123(08)60552-X","article-title":"Dynamics of local neuronal networks: Control parameters and state bifurcations in epileptogenesis","volume":"102","author":"Lopes","year":"1994","journal-title":"Prog Brain Res"},{"key":"10.3233\/JAD-210209_ref60","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clinph.2004.01.001","article-title":"EEG dynamics in patients with Alzheimer\u2019s disease","volume":"115","author":"Jeong","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.3233\/JAD-210209_ref61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0167-2789(92)90102-S","article-title":"Testing for nonlinearity in time series: The method of surrogate data","volume":"58","author":"Theiler","year":"1992","journal-title":"Phys D Nonlinear Phenom"},{"key":"10.3233\/JAD-210209_ref62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpsycho.2015.02.001","article-title":"Review of evoked and event-related delta responses in the human brain","volume":"103","author":"G\u00fcntekin","year":"2016","journal-title":"Int J Psychophysiol"},{"key":"10.3233\/JAD-210209_ref63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clinph.2019.06.234","article-title":"International Federation of Clinical Neurophysiology (IFCN) \u2013EEG research workgroup: Recommendations on frequency and topographic analysis of resting state EEG rhythms. Part 1: Applications in clinical research studies","volume":"131","author":"Babiloni","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.3233\/JAD-210209_ref64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neurobiolaging.2016.04.016","article-title":"Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer\u2019s disease","volume":"44","author":"Hazra","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210209_ref65","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1038\/s41598-020-68845-y","article-title":"Response of spike-wave discharges in aged APP\/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs","volume":"10","author":"Jin","year":"2020","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-210209_ref66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jnc.12127","article-title":"Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer\u2019s disease","volume":"125","author":"Zilberter","year":"2013","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-210209_ref67","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1567205013666160129095508","article-title":"Increased epileptiform EEG activity and decreased seizure threshold in arctic APP transgenic mouse model of Alzheimer\u2019s disease","volume":"13","author":"Ziyatdinova","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-210209_ref68","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","article-title":"Tau loss attenuates neuronal network hyperexcitability in mouse and drosophila genetic models of epilepsy","volume":"33","author":"Holth","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-210209_ref69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eplepsyres.2014.11.017","article-title":"Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer\u2019s disease","volume":"110","author":"Warner","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.3233\/JAD-210209_ref70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neurobiolaging.2018.08.002","article-title":"Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP\/PSEN1 mice","volume":"71","author":"Mi","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210209_ref71","doi-asserted-by":"crossref","first-page":"825157","DOI":"10.1155\/2015\/825157","article-title":"Limited effects of an eIF2\u03b1 S51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"2015","author":"Paesler","year":"2015","journal-title":"Neural Plast"},{"key":"10.3233\/JAD-210209_ref72","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","article-title":"Amyloid-\u03b2\/fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-210209_ref73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-00936-3","article-title":"Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model","volume":"8","author":"Abe","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-210209_ref74","first-page":"178","article-title":"Environmental enrichment does not influence hypersynchronous network activity in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"23","author":"Bezzina","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-210209_ref75","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"key":"10.3233\/JAD-210209_ref76","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2014.03.029","article-title":"Bexarotene reduces network excitability in models of Alzheimer\u2019s disease and epilepsy","volume":"35","author":"Bomben","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210209_ref77","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","article-title":"Antisense reduction of tau in adult mice protects against seizures","volume":"33","author":"DeVos","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-210209_ref78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2012.05.048","article-title":"Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice","volume":"1467","author":"Hunter","year":"2012","journal-title":"Brain Res"},{"key":"10.3233\/JAD-210209_ref79","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.nbd.2017.07.012","article-title":"Metabolic correction by pyruvate halts acquired epilepsy in multiple rodent models","volume":"106","author":"Popova","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-210209_ref80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s40478-014-0149-z","article-title":"p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer\u2019s disease","volume":"2","author":"Ittner","year":"2014","journal-title":"Acta Neuropathol Commun"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-210209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:21Z","timestamp":1777370781000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-210209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":80,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-210209","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]}}}